Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02530658 : Next Generation Sequencing of Tumor and Normal Tissues Prospectively in Pediatric Oncology Patients at St. Jude Children's Research Hospital
PhaseN/A
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- New St. Jude patients prospectively identified at the time of study activation with:

- Newly diagnosed solid or liquid tumor (benign or malignant),

- Relapsed solid or liquid tumor (benign or malignant), or

- Refractory solid or liquid tumor (benign or malignant)

- Current St. Jude patients who develop a new mass and undergo a surgical procedure to
establish the diagnosis of recurrent disease or a new primary tumor.

- Current St. Jude patients who, while on therapy, develop refractory disease and
undergo a surgical procedure to palliate symptoms.

- Adequate tissue must be available (e.g. sufficient germline and/or tumor tissue, from
which >1 µg DNA and >0.1 µg RNA must be isolated). Patients with retinoblastoma,
diffuse intrinsic pontine glioma, craniopharyngioma, or optic pathway tumors who have
no tumor tissue available may enroll using only a germline sample.

Exclusion Criteria:

- Past history of hematopoietic stem cell transplantation (or other condition that
would result in hematopoietic cell DNA failing to match host tissue DNA).

- Tumor or germline tissue not meeting the criteria listed above.

- Inability or unwillingness of research participant or legal guardian/representative
to give written informed consent.

- Participants who are unable to read, write or converse fluently in English will be
excluded from Prespecified Objectives 3 and 4.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02530658      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740